Last Transcript: AB Science

1 day+0.78%
1 week-11.56%
Current month-12.66%
1 month-16.88%
3 months-34.60%
6 months-47.05%
Current year-49.67%
1 week 0.72
Extreme 0.723
0.91
1 month 0.72
Extreme 0.723
0.94
Current year 0.72
Extreme 0.723
1.61
1 year 0.72
Extreme 0.723
1.73
3 years 0.72
Extreme 0.723
4.46
5 years 0.72
Extreme 0.723
16.68
10 years 0.72
Extreme 0.723
21.75
Manager TitleAgeSince
Chief Executive Officer - 10/07/2001
Director of Finance/CFO - 19/11/2009
Chief Tech/Sci/R&D Officer - 31/03/2018
Director TitleAgeSince
Chairman - 10/07/2001
Director/Board Member - 19/09/2011
Director/Board Member 64 26/06/2021
Date Insider Type Main position Quantity % Market Cap.
05-19Sell

Chief Executive Officer

-573 0.0009%
08/02/21Sell

Founder

14,525 0.0315%
01/02/21Sell

Founder

12,904 0.0280%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%-11.56%-52.46%-81.37% 70.75M
+3.34%+0.70%+60.09%+13.32% 320B
-1.25%0.00%+30.92%-1.55% 72.44B
+3.17%+5.99%+47.13%+115.43% 9.42B
+1.24%+4.51%+5.99%+0.26% 8.65B
+8.48%+25.95%+25.73%+38.15% 4.52B
-0.46%+3.98%-5.69%+3.61% 4.41B
+0.43%+6.02%-33.90%+24.44% 3.43B
+1.35%+2.58%+50.25%+60.70% 2.79B
-1.28%+7.61%+15.27%-23.79% 2.19B
Average +1.58%+1.63%+14.33%+14.92% 42.79B
Weighted average by Cap. +2.47%+2.84%+51.67%+13.14%
Logo AB Science
AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.
Employees
31
Date Price Change Volume
03/07/26 €0.7730 +0.78% 308,587
02/07/26 €0.7670 -1.67% 745,893
01/07/26 €0.7800 -11.86% 1,205,200
30/06/26 €0.8850 -1.45% 91,989
29/06/26 €0.8980 +2.75% 192,261